Navigation Links
The 'febit science lounge' presents: Webinar About Role of Non-Protein-Coding RNA in Human Genome Set for 11 a.m. EDT on June 12
Date:6/5/2008

'The human genome as an RNA machine' with Prof. John Mattick with Institute

for Molecular Bioscience at University of Queensland, Australia

LEXINGTON, Mass. and HEIDELBERG, Germany, June 5 /PRNewswire/ -- febit holding gmbh today unveiled plans for the first of a series of educational Webinars geared for genomics researchers worldwide.

Moderated by febit's chief scientific officer, Peer Staehler, the first Webinar, which is set for 11 a.m. EDT on June 12, will feature John Mattick, Ph.D., a world-renowned researcher whose focus is the role of non-protein-coding ("junk") RNA in relation to the evolution and development of complex organisms.

"Genetic information that programs complex organisms lie in non-protein coding RNA," said Dr. Mattick, foundation professor of molecular biology and director of the Centre for Molecular Biology and Biotechnology, with the Institute for Molecular Bioscience at the University of Queensland, Australia. "This massive hidden network of regulatory information directs the precise patterns of gene expression during growth and development."

Mr. Staehler added: "This educational Webinar for the genomics researchers is the first of many to come. The team at febit is dedicated to support researchers to solve the challenge of understanding biological processes."

To participate in the Webinar, register at http://www.febit.com. Please connect to the Webinar several minutes prior to the start time to ensure adequate time for any software download that may be necessary. The live event may also be accessed by dialing 877-715-5318 (for U.S. callers) and 973-582-2852 (for international callers) and entering conference ID 50057678. Questions may be asked over the telephone during the live event or e-mailed in advance to webinar@febit.com. The Webinar will be available for replay for one year on febit's Web site.

About febit

febit enables scientists to read, write and understand the code of life: DNA. With its unique Geniom technology and services, febit is the only company that puts the control of simplified genomic research in the hand of the user. The seamless integration of DNA synthesis and analysis and the superior support in experiment design and bioinformatics helps to understand data and turn it into results. febit's team of experienced scientists is dedicated to support customers to solve the challenge of understanding biological processes. Geniom is a technological and service platform successfully implemented in basic and applied research by renowned institutions and companies. Geniom exploits cutting-edge microarray technology for analysis and synthesis of genes and genomes, providing superior time- and cost-efficiency combined with an unsurpassed spectrum of applications.

http://www.febit.com

Contact:

febit holding gmbh Russo Partners, LLC

Eva Sterzel David Schull or Wendy Lau

Public Relations Manager +1-212-845-4271

+49 (6221) 6510-300 david.schull@russopartnersllc.com

eva.sterzel@febit.de wendy.lau@russopartnersllc.com


'/>"/>
SOURCE febit
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
2. Penn scientist receives LOréal USA fellowship for women in science
3. Edwards Lifesciences to Present at the Goldman Sachs 29th Annual Global Healthcare Conference
4. Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming WUWHS Conference
5. Medical Simulation Corporation Announces Partnership With Seattle Science Foundation
6. Edwards Lifesciences Receives Additional Questions From the FDA About the LifeStent Product Line
7. New federally-funded health initiative to speed benefits of science to North Carolinians
8. Harvard Medical School receives major NIH grant for galvanizing translational science
9. BUMC, BMC receives Clinical and Translational Science Award from NIH
10. Experts to discuss sleep science and the health risks of sleep disorders in Baltimore this June
11. 1 small step for a lab science, 1 green leap for mankind
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary ... Work award to iHire in recognition of their exemplary accomplishments in worksite health promotion. ... Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... 2016 Dublin ... addition of the " Global Markets for Spectroscopy ... This report focuses on the ... review, including its applications in various applications. The report ... includes three main industries: pharmaceutical and biotechnology, food and ...
Breaking Medicine Technology: